Gilead Sciences (GILD) Deferred Taxes (2009 - 2026)

Gilead Sciences (GILD) has reported Deferred Taxes for 18 consecutive years, with -$587.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Deferred Taxes fell 229.78% year-over-year to -$587.0 million; the trailing twelve-month figure through Jun 2026 stood at $129.0 million (up 109.68% YoY), and the FY2025 full-year result was $160.0 million, up 108.68% from the prior year.
• Deferred Taxes eased to -$587.0 million in Q2 2026 per GILD's latest filing, from $179.0 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $659.0 million in Q3 2025 and bottomed at -$723.0 million in Q1 2024.
• Historically, Deferred Taxes has averaged -$255.9 million across 5 years, with a median of -$281.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Deferred Taxes plunged 1016.9% in 2022, then soared 214.41% in 2025.
• Over 5 years, Deferred Taxes stood at -$338.0 million in 2022, then declined by 9.47% to -$370.0 million in 2023, then slipped by 2.43% to -$379.0 million in 2024, then surged by 67.81% to -$122.0 million in 2025, then sank by 381.15% to -$587.0 million in 2026.
• According to Business Quant data, Deferred Taxes over the past three periods registered -$587.0 million, $179.0 million, and -$122.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.